Cargando…

Impact of the COVID-19 Controlled Drugs and Substances Act exemption on pharmacist prescribing of opioids, benzodiazepines and stimulants in Ontario: A cross-sectional time-series analysis

BACKGROUND: Due to the coronavirus disease 2019 (COVID-19) pandemic, Health Canada issued an exemption to the Controlled Drugs and Substances Act (CDSA) on March 19, 2020, enabling pharmacists to act as prescribers of controlled substances to support continuity of care. Our study investigates utiliz...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chang, Ann, Chaudhry, Shanzeh, McCormack, Daniel, Gomes, Tara, Shivji, Anisa, Tadrous, Mina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Research and Clinical
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647400/ https://www.ncbi.nlm.nih.gov/pubmed/36386607 http://dx.doi.org/10.1177/17151635221126481

Ejemplares similares

Contributions of prescribed and non-prescribed opioids to opioid related deaths: population based cohort study in Ontario, Canada
por: Gomes, Tara, et al.
Publicado: (2018)

Pharmacists’ perceptions of the Canadian opioid regulatory exemptions on patient care and opioid stewardship
por: Bishop, Lisa D., et al.
Publicado: (2021)

The epidemiology of benzodiazepine-related toxicity in Ontario, Canada: a population-based descriptive study
por: Campbell, Tonya J., et al.
Publicado: (2023)

Measuring the Burden of Opioid-related Mortality in Ontario, Canada
por: Gomes, Tara, et al.
Publicado: (2018)

Effect of listing strategies on utilization of antitumor necrosis factor biologics infliximab and etanercept: a cross-sectional analysis from Ontario, Canada
por: Fenna, Jennifer, et al.
Publicado: (2021)

Duration of use and outcomes among people with opioid use disorder initiating methadone and buprenorphine in Ontario: a population‐based propensity‐score matched cohort study
por: Gomes, Tara, et al.
Publicado: (2022)

Effect of Pharmacist Email Alerts on Concurrent Prescribing of Opioids and Benzodiazepines by Prescribers and Primary Care Managers: A Randomized Clinical Trial
por: Sacarny, Adam, et al.
Publicado: (2022)

Effects of an academic detailing service on benzodiazepine prescribing patterns in primary care
por: Lacroix, Meagan, et al.
Publicado: (2023)

Opioid and benzodiazepine prescribing after COVID‐19 hospitalization
por: Delaney, Lia D., et al.
Publicado: (2022)

Impact of changes in opioid funding and clinical policies on rapid tapering of opioids in Ontario, Canada
por: Martins, Diana, et al.
Publicado: (2022)

Impact of delisting high‐strength opioid formulations from a public drug benefit formulary on opioid utilization in Ontario, Canada
por: Martins, Diana, et al.
Publicado: (2019)

Is it safe to prescribe benzodiazepines or opioids for dyspnoea in interstitial lung disease?
por: Finney, Lydia J.
Publicado: (2019)

Behind the Counter: Exploring Pharmacists’ Stressors and Lessons Learned During the Pandemic in Ontario, Canada
por: Zahoor, Zoha, et al.
Publicado: (2023)

Preliminary Investigation of Pharmacist-Delivered, Direct-to-Provider Interventions to Reduce Co-Prescribing of Opioids and Benzodiazepines among a Medicare Population
por: Bingham, Jennifer M., et al.
Publicado: (2020)

Projected impact of biosimilar substitution policies on drug use and costs in Ontario, Canada: a cross-sectional time series analysis
por: Gomes, Tara, et al.
Publicado: (2021)

Impact of a Publicly Funded Herpes Zoster Immunization Program on the Burden of Disease in Ontario, Canada: A Population-based Study
por: Martins, Diana, et al.
Publicado: (2020)

Pharmacist Prescribing for Minor Ailments Service Development: The Experience in Ontario
por: Nakhla, Nardine, et al.
Publicado: (2021)

Impact of a publicly-funded pharmacare program policy on benzodiazepine dispensing among children and youth: a population-based natural experiment
por: Antoniou, Tony, et al.
Publicado: (2023)

Opioid stewardship: implementing a proactive, pharmacist-led intervention for patients coprescribed opioids and benzodiazepines at an urban academic primary care centre
por: Tilli, Tiana, et al.
Publicado: (2020)

Primary-Care Prescribers’ Perspectives on Deprescribing Opioids and Benzodiazepines in Older Adults
por: Niznik, Joshua D., et al.
Publicado: (2022)

The impact of benzodiazepine use in patients enrolled in opioid agonist therapy in Northern and rural Ontario
por: Franklyn, Alexandra M., et al.
Publicado: (2017)

Clinical outcomes and health care costs among people entering a safer opioid supply program in Ontario
por: Gomes, Tara, et al.
Publicado: (2022)

Clinical indications associated with opioid initiation for pain management in Ontario, Canada: a population-based cohort study
por: Pasricha, Sachin V., et al.
Publicado: (2018)

Changing patterns of opioid initiation for pain management in Ontario, Canada: A population-based cross-sectional study
por: Gomes, Tara, et al.
Publicado: (2022)

New Opioid Use and Risk of Emergency Department Visits Related to Motor Vehicle Collisions in Ontario, Canada
por: Guan, Qi, et al.
Publicado: (2021)

Erratum to: The impact of benzodiazepine use in patients enrolled in opioid agonist therapy in Northern and rural Ontario
por: Franklyn, Alexandra M., et al.
Publicado: (2017)

Appropriate prescribing in nursing homes demonstration project (APDP) study protocol: pragmatic, cluster-randomized trial and mixed methods process evaluation of an Ontario policy-maker initiative to improve appropriate prescribing of antipsychotics
por: Desveaux, Laura, et al.
Publicado: (2016)

Geographic variation and sociodemographic correlates of prescription psychotropic drug use among children and youth in Ontario, Canada: a population-based study
por: Antoniou, Tony, et al.
Publicado: (2023)

Association of Electronic Prescribing of Controlled Substances With Opioid Prescribing Rates
por: Everson, Jordan, et al.
Publicado: (2020)

Benzodiazepine prescribing patterns and drug overdose mortality among individuals receiving opioid analgesics
por: Park, Tae Woo, et al.
Publicado: (2015)

Association Between Receipt of Overlapping Opioid and Benzodiazepine Prescriptions From Multiple Prescribers and Overdose Risk
por: Chua, Kao-Ping, et al.
Publicado: (2021)

Changes in Concurrent Opioid and Benzodiazepine Use Following a Low-Touch Prescriber Fax Intervention
por: Yang, Rochelle, et al.
Publicado: (2020)

Prevalence and nature of manufacturer-sponsored patient support programs for prescription drugs in Canada: a cross-sectional study
por: Grundy, Quinn, et al.
Publicado: (2023)

The Risk of Ventricular Dysrhythmia or Sudden Death in Patients Receiving Serotonin Reuptake Inhibitors With Methadone: A Population-Based Study
por: Antoniou, Tony, et al.
Publicado: (2022)

Comparison of claims from high–drug cost beneficiaries in Ontario, Canada, and Australia: a cross-sectional analysis
por: Tadrous, Mina, et al.
Publicado: (2021)

Impact of the COVID-19 pandemic on the prevalence of opioid agonist therapy discontinuation in Ontario, Canada: A population-based time series analysis
por: Garg, Ria, et al.
Publicado: (2022)

The Ontario Pharmacy Evidence Network Interactive Atlas of Professional Pharmacist Services
por: Cadarette, Suzanne M., et al.
Publicado: (2021)

The uptake of the pharmacy-dispensed naloxone kit program in Ontario: A population-based study
por: Choremis, Beatrice, et al.
Publicado: (2019)

The Exempts
Publicado: (1891)

Impact of the COVID-19 pandemic on the provision of take-home doses of opioid agonist therapy in Ontario, Canada: A population-based time-series analysis
por: Kitchen, Sophie A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t36us9251atn7uttlg16cqsb8f